If You'd Invested $10,000 in Moderna's IPO, Here's How Much Money You'd Have Now
Buying Moderna (NASDAQ: MRNA) at its initial public offering (IPO) is a great example. While the overall stock market is still down year to date even after a solid rebound, shares of Moderna have skyrocketed close to 250% higher this so far year. Investors have flocked to the biotech stock because of the company's promising COVID-19 vaccine candidate.